Cargando…

Cholangitis in patients with atrial fibrillation: A retrospective cohort study in Taiwan

The purpose of this study is to investigate whether atrial fibrillation (AF) and cholangitis is associated. This is a propensity-matched retrospective cohort report from the Taiwan National Health Insurance Research Database. We included patients who had AF but didn’t have cholangitis, and matched c...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Wei-Syun, Lin, Cheng-Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8830825/
https://www.ncbi.nlm.nih.gov/pubmed/35147112
http://dx.doi.org/10.1097/MD.0000000000028797
_version_ 1784648360008876032
author Hu, Wei-Syun
Lin, Cheng-Li
author_facet Hu, Wei-Syun
Lin, Cheng-Li
author_sort Hu, Wei-Syun
collection PubMed
description The purpose of this study is to investigate whether atrial fibrillation (AF) and cholangitis is associated. This is a propensity-matched retrospective cohort report from the Taiwan National Health Insurance Research Database. We included patients who had AF but didn’t have cholangitis, and matched controls between January 1, 2000 and December 31, 2012. The AF cohort comprised 114,572 patients and the comparison cohort comprised 114,572 subjects. All participants were followed up until developing cholangitis, death, or December 31, 2013, whichever came first. The cox model was used to calculate the adjusted hazard ratios (HRs) and 95% confidence intervals (CIs) for comparing the risk of cholangitis in the AF cohort and non-AF cohort. The incidence of cholangitis was higher in patients with AF than in those without AF [4.2 and 2.54 per 1000 person–years; adjusted HR (95%CI), 1.92 (1.54, 2.41)]. Comparing to subjects without AF, patients with AF had higher risk of cholangitis in the subgroup of ≥65 years (adjusted HR = 1.76, 95%CI = 1.40–2.21), female (adjusted HR = 2.51, 95%CI = 1.74–3.63), male (adjusted HR = 1.60, 95%CI = 1.19–2.14), without comorbidities (adjusted HR = 1.79, 95%CI = 1.23–2.61), and with comorbidities (adjusted HR = 1.85, 95%CI = 1.73–1.99). AF is associated with a higher incidence of cholangitis. The need of further investigations is mandatory because of the inherent limitations of observational study.
format Online
Article
Text
id pubmed-8830825
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-88308252022-02-15 Cholangitis in patients with atrial fibrillation: A retrospective cohort study in Taiwan Hu, Wei-Syun Lin, Cheng-Li Medicine (Baltimore) 4400 The purpose of this study is to investigate whether atrial fibrillation (AF) and cholangitis is associated. This is a propensity-matched retrospective cohort report from the Taiwan National Health Insurance Research Database. We included patients who had AF but didn’t have cholangitis, and matched controls between January 1, 2000 and December 31, 2012. The AF cohort comprised 114,572 patients and the comparison cohort comprised 114,572 subjects. All participants were followed up until developing cholangitis, death, or December 31, 2013, whichever came first. The cox model was used to calculate the adjusted hazard ratios (HRs) and 95% confidence intervals (CIs) for comparing the risk of cholangitis in the AF cohort and non-AF cohort. The incidence of cholangitis was higher in patients with AF than in those without AF [4.2 and 2.54 per 1000 person–years; adjusted HR (95%CI), 1.92 (1.54, 2.41)]. Comparing to subjects without AF, patients with AF had higher risk of cholangitis in the subgroup of ≥65 years (adjusted HR = 1.76, 95%CI = 1.40–2.21), female (adjusted HR = 2.51, 95%CI = 1.74–3.63), male (adjusted HR = 1.60, 95%CI = 1.19–2.14), without comorbidities (adjusted HR = 1.79, 95%CI = 1.23–2.61), and with comorbidities (adjusted HR = 1.85, 95%CI = 1.73–1.99). AF is associated with a higher incidence of cholangitis. The need of further investigations is mandatory because of the inherent limitations of observational study. Lippincott Williams & Wilkins 2022-02-11 /pmc/articles/PMC8830825/ /pubmed/35147112 http://dx.doi.org/10.1097/MD.0000000000028797 Text en Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC), where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc/4.0 (https://creativecommons.org/licenses/by-nc/4.0/)
spellingShingle 4400
Hu, Wei-Syun
Lin, Cheng-Li
Cholangitis in patients with atrial fibrillation: A retrospective cohort study in Taiwan
title Cholangitis in patients with atrial fibrillation: A retrospective cohort study in Taiwan
title_full Cholangitis in patients with atrial fibrillation: A retrospective cohort study in Taiwan
title_fullStr Cholangitis in patients with atrial fibrillation: A retrospective cohort study in Taiwan
title_full_unstemmed Cholangitis in patients with atrial fibrillation: A retrospective cohort study in Taiwan
title_short Cholangitis in patients with atrial fibrillation: A retrospective cohort study in Taiwan
title_sort cholangitis in patients with atrial fibrillation: a retrospective cohort study in taiwan
topic 4400
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8830825/
https://www.ncbi.nlm.nih.gov/pubmed/35147112
http://dx.doi.org/10.1097/MD.0000000000028797
work_keys_str_mv AT huweisyun cholangitisinpatientswithatrialfibrillationaretrospectivecohortstudyintaiwan
AT linchengli cholangitisinpatientswithatrialfibrillationaretrospectivecohortstudyintaiwan